Danielle Cherrick, MD
Physical Medicine & Rehabilitation · Mc Lean, VANPI 1346534856
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 205 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 35 manufacturers reported payments, led by Abbott at 32.3% of the total. Reporting peaked in 2019 at $2,164 and has fallen 56.3% since, to $946 in 2025. Among physical medicine & rehabilitation clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 205 payments — averaging $31.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Medtronic$878
- Collegium Pharmaceutical, Inc.$656
- SPR Therapeutics, Inc$441
- Foundation Fusion Solutions, LLC$383
- Merz North America, Inc.$221
- plus $2K from 29 others
What the payments were for
- Food & beverage$6,471100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 40 | $2,093 |
| Medtronic(2 entities) | 13 | $878 |
| Collegium Pharmaceutical, Inc. | 54 | $656 |
| SPR Therapeutics, Inc | 4 | $441 |
| Foundation Fusion Solutions, LLC | 2 | $383 |
| Merz North America, Inc. | 3 | $221 |
| Nevro Corp. | 3 | $198 |
| Teva Pharmaceuticals USA, Inc. | 14 | $156 |
| Biodelivery Sciences International, Inc. | 4 | $154 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $133 |
| Relievant Medsystems, Inc. | 2 | $130 |
| Pfizer | 10 | $119 |
| Sentynl Therapeutics, Inc. | 6 | $104 |
| Si-bone, Inc. | 1 | $92 |
| Scilex Pharmaceuticals Inc. | 5 | $89 |
| Novartis | 4 | $81 |
| Pacira Therapeutics, Inc. | 2 | $57 |
| Zyla Life Sciences, Inc. | 4 | $53 |
| AbbVie(2 entities) | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $48 |
| Forte Bio-pharma LLC | 1 | $38 |
| Assertio Therapeutics, Inc. | 2 | $35 |
| Lilly USA, LLC | 2 | $31 |
| Boston Scientific | 2 | $29 |
| Amgen(2 entities) | 2 | $26 |
| Stryker | 1 | $24 |
| MDD US Operations, LLC | 1 | $22 |
| Ferring Pharmaceuticals Inc. | 1 | $19 |
| Virtus Pharmaceuticals LLC | 1 | $19 |
| Averitas Pharma Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| AstraZeneca | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Shionogi Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$353
- ETERNA$263
- SPRINT PNS System$258
- DURATA$147
- Senza$143
- XEOMIN$124
- BELBUCA$114
- Prodigy Family of SCS IPGs$113
- INTELLIS$111
- ASCENDA$110
- SYNCHROMED$106
How this compares
$6,471 in reported general payments places this provider in the 95th percentile of 231 physical medicine & rehabilitation providers in Virginia.
See all physical medicine & rehabilitation providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 18 | $20,246 |
| Xtampza ErOxycodone Myristate | 20 | $12,532 |
| MovantikNaloxegol Oxalate | 18 | $7,178 |
| Gabapentin | 338 | $4,380 |
| Pregabalin | 142 | $3,488 |
| Fentanyl | 17 | $2,814 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 126 | $2,631 |
| Buprenorphine | 15 | $2,160 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 93 | $1,553 |
| Oxycodone Hcl | 95 | $1,511 |
| Lidocaine | 12 | $1,420 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 64 | $979 |
| Tramadol Hcl | 127 | $901 |
| Duloxetine Hcl | 60 | $797 |
| Celecoxib | 49 | $562 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $656 | $12,53220 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 231 physical medicine & rehabilitation providers in Virginia.
Other physical medicine & rehabilitation in Mc Lean
- Rosemarie FilartMc Lean$4K
- Kovosh DastanWinchester$23K
- Stephanie ClopAldie$16K
- Daniel HellerWarrenton$12K
- Amanda MoranNorfolk$9K
- Abraham CherrickAlexandria$9K
- Mir AliRichmond$8K
- Derek BuckBluefield$7K
- Christopher TrowerVirginia Beach$6K
- Harnek BajajRichmond$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.